查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
过敏疾病标靶药物的全球市场的考察，预测(～2030年)
市场调查报告书
商品编码
1432271

过敏疾病标靶药物的全球市场的考察，预测(～2030年)

Global Targeted Drugs for Allergic Diseases Market Insights, Forecast to 2030
出版日期: | 出版商: QYResearch | 英文 263 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球过敏性疾病标靶药物市场规模预计将从 2024 年的 3714912 万美元增至 2030 年的 9106996 万美元，预测期内复合年增长率为 16.12%。

美国-加拿大市场预计将从 2024 年的 248.1798 亿美元增至 2030 年的 474.4929 亿美元，2025-2030 年预测期间复合年增长率为 11.41%。

中国市场预计将从 2024 年的 23.0336 亿美元增至 2030 年的 165.2416 亿美元，预测期内复合年增长率为 38.88%。

欧洲市场预计将从 2024 年的 65.9313 亿美元增至 2030 年的 157.0486 亿美元，预测期内复合年增长率为 15.56%。

生产过敏性疾病标靶药物的全球领导公司包括赛诺菲、艾伯维、诺华、因塞特、罗氏、阿斯特捷利康、葛兰素史克、礼来公司、安进、辉瑞、Leo Pharma、梯瓦製药、大冢製药和Mabpharm。2023年，全球前五名企业的营收占比约为75.25%。

本报告提供全球过敏疾病标靶药物市场相关调查分析，提供各地区市场规模与预测，市场动态，竞争情形等资讯。

目录

第1章 报告概要

  • 调查范围
  • 市场分析:各类型
    • 全球过敏疾病标靶药物的市场规模成长率:各类型(2019年·2023年·2030年)
    • IL-4R
    • TSLP
    • IL-5
    • JAK
    • IgE
    • IL-13
  • 市场:各用途
    • 全球过敏疾病标靶药物的市场占有率:各用途(2019年·2023年·2030年)
    • 异位性皮肤炎
    • 气喘
    • 慢性鼻窦炎伴随鼻息肉
    • 慢性阻塞性肺病
    • 其他
  • 前提条件与限制
  • 调查目的
  • 调查年

第2章 全球成长趋势

  • 全球过敏疾病标靶药物市场预测(2019年～2030年)
  • 全球过敏疾病标靶药物成长趋势:各地区
    • 全球过敏疾病标靶药物的市场规模:各地区(2019年·2023年·2030年)
    • 过敏疾病标靶药物的市场规模的实际成果:各地区(2019年～2024年)
    • 过敏疾病标靶药物的市场规模的预测:各地区(2025年～2030年)
  • 过敏疾病标靶药物的市场动态
    • 过敏疾病标靶药物趋势趋势
    • 过敏疾病标靶药物市场促进因素
    • 过敏疾病标靶药物市场课题
    • 过敏疾病标靶药物市场阻碍因素

第3章 竞争情形:各主要企业

  • 全球过敏疾病标靶药物的收益目标:各企业
    • 全球过敏疾病标靶药物的收益:各企业(2019年～2024年)
    • 全球过敏疾病标靶药物的收益的市场占有率:各企业(2019年～2024年)
  • 全球过敏疾病标靶药物的市场占有率:各类型企业(Tier 1·Tier 2·Tier 3)
  • 全球过敏疾病标靶药物的主要企业，销售额排行榜(2022年·2023年·2024年)
  • 全球过敏疾病标靶药物的市场集中度
    • 全球过敏疾病标靶药物的市场集中度(CR5)
    • 全球过敏疾病标靶药物的收益的前五名公司(2023年)
  • 全球过敏疾病标靶药物的主要企业的总公司，服务提供区域
  • 全球过敏疾病标靶药物的主要企业的产品类型
  • 全球过敏疾病标靶药物的主要企业的创设日
  • 合併和收购，扩张计划

第4章 过敏疾病标靶药物的明细资料:各类型

  • 全球过敏疾病标靶药物的市场规模的实际成果:各类型(2019年～2024年)
  • 全球过敏疾病标靶药物的市场规模的预测:各类型(2025年～2030年)

第5章 过敏疾病标靶药物的明细资料:各用途

  • 全球过敏疾病标靶药物的市场规模的实际成果:各用途(2019年～2024年)
  • 全球过敏疾病标靶药物的市场规模的预测:各用途(2025年～2030年)

第6章 北美

  • 北美的过敏疾病标靶药物的市场规模(2019年～2030年)
  • 北美的过敏疾病标靶药物的市场规模:各类型
    • 北美的过敏疾病标靶药物的市场规模:各类型(2019年～2024年)
    • 北美的过敏疾病标靶药物的市场规模:各类型(2025年～2030年)
    • 北美的过敏疾病标靶药物的市场占有率:各类型(2019年～2030年)
  • 北美的过敏疾病标靶药物的市场规模:各用途
    • 北美的过敏疾病标靶药物的市场规模:各用途(2019年～2024年)
    • 北美的过敏疾病标靶药物的市场规模:各用途(2025年～2030年)
    • 北美的过敏疾病标靶药物的市场占有率:各用途(2019年～2030年)
  • 北美的过敏疾病标靶药物的市场规模:各国
    • 北美的过敏疾病标靶药物的市场规模:各国(2019年·2023年·2030年)
    • 北美的过敏疾病标靶药物的市场规模:各国(2019年～2024年)
    • 北美的过敏疾病标靶药物的市场占有率:各国(2025年～2030年)
    • 美国
    • 加拿大

第7章 欧洲

  • 欧洲的过敏疾病标靶药物的市场规模(2019年～2030年)
  • 欧洲的过敏疾病标靶药物的市场规模:各类型
    • 欧洲的过敏疾病标靶药物的市场规模:各类型(2019年～2024年)
    • 欧洲的过敏疾病标靶药物的市场规模:各类型(2025年～2030年)
    • 欧洲的过敏疾病标靶药物的市场占有率:各类型(2019年～2030年)
  • 欧洲的过敏疾病标靶药物的市场规模:各用途
    • 欧洲的过敏疾病标靶药物的市场规模:各用途(2019年～2024年)
    • 欧洲的过敏疾病标靶药物的市场规模:各用途(2025年～2030年)
    • 欧洲的过敏疾病标靶药物的市场占有率:各用途(2019年～2030年)
  • 欧洲的过敏疾病标靶药物的市场规模:各国
    • 欧洲的过敏疾病标靶药物的市场规模:各国(2019年·2023年·2030年)
    • 欧洲的过敏疾病标靶药物的市场规模:各国(2019年～2024年)
    • 欧洲的过敏疾病标靶药物的市场规模:各国(2025年～2030年)
    • 德国
    • 法国
    • 英国
    • 义大利
    • 俄罗斯

第8章 中国

  • 中国的过敏疾病标靶药物的市场规模(2019年～2030年)
  • 中国的过敏疾病标靶药物的市场规模:各类型
    • 中国的过敏疾病标靶药物的市场规模:各类型(2019年～2024年)
    • 中国的过敏疾病标靶药物的市场规模:各类型(2025年～2030年)
    • 中国的过敏疾病标靶药物的市场占有率:各类型(2019年～2030年)
  • 中国的过敏疾病标靶药物的市场规模:各用途
    • 中国的过敏疾病标靶药物的市场规模:各用途(2019年～2024年)
    • 中国的过敏疾病标靶药物的市场规模:各用途(2025年～2030年)
    • 瞄准中国的过敏疾病标靶药物的市场占有率的:各用途(2019年～2030年)

第9章 亚洲(中国以外)

  • 亚洲的过敏疾病标靶药物的市场规模(2019年～2030年)
  • 亚洲的过敏疾病标靶药物的市场规模:各类型
    • 亚洲的过敏疾病标靶药物的市场规模:各类型(2019年～2024年)
    • 亚洲的过敏疾病标靶药物的市场规模:各类型(2025年～2030年)
    • 亚洲的过敏疾病标靶药物的市场占有率:各类型(2019年～2030年)
  • 亚洲的过敏疾病标靶药物的市场规模:各用途
    • 亚洲的过敏疾病标靶药物的市场规模:各用途(2019年～2024年)
    • 亚洲的过敏疾病标靶药物的市场规模:各用途(2025年～2030年)
    • 亚洲的过敏疾病标靶药物的市场占有率:各用途(2019年～2030年)
  • 亚洲的过敏疾病标靶药物的市场规模:各地区
    • 亚洲的过敏疾病标靶药物市场市场规模:各地区(2019年·2023年·2030年)
    • 亚洲的过敏疾病标靶药物的市场规模:各地区(2019年～2024年)
    • 亚洲的过敏疾病标靶药物的市场规模:各地区(2025年～2030年)
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲

第10章 南美

  • 南美的过敏疾病标靶药物的市场规模(2019年～2030年)
  • 南美的过敏疾病标靶药物的市场规模:各类型
    • 南美的过敏疾病标靶药物的市场规模:各类型(2019年～2024年)
    • 南美的过敏疾病标靶药物的市场规模:各类型(2025年～2030年)
    • 南美的过敏疾病标靶药物的市场占有率:各类型(2019年～2030年)
  • 南美的过敏疾病标靶药物的市场规模:各用途
    • 南美的过敏疾病标靶药物的市场规模:各用途(2019年～2024年)
    • 南美的过敏疾病标靶药物的市场规模:各用途(2025年～2030年)
    • 南美的过敏疾病标靶药物的市场占有率:各用途(2019年～2030年)
  • 南美的过敏疾病标靶药物的市场规模:各国
    • 南美的过敏疾病标靶药物的市场规模:各国(2019年·2023年·2030年)
    • 南美的过敏疾病标靶药物的市场规模:各国(2019年～2024年)
    • 南美的过敏疾病标靶药物的市场规模:各国(2025年～2030年)
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚

第11章 中东·非洲

  • 中东·非洲的过敏疾病标靶药物的市场规模(2019年～2030年)
  • 中东·非洲的过敏疾病标靶药物的市场规模:各类型
    • 中东·非洲的过敏疾病标靶药物的市场规模:各类型(2019年～2024年)
    • 中东·非洲的过敏疾病标靶药物的市场规模:各类型(2025年～2030年)
    • 中东·非洲的过敏疾病标靶药物的市场占有率:各类型(2019年～2030年)
  • 中东·非洲的过敏疾病标靶药物的市场规模:各用途
    • 中东·非洲的过敏疾病标靶药物的市场规模:各用途(2019年～2024年)
    • 中东·非洲的过敏疾病标靶药物的市场规模:各用途(2025年～2030年)
    • 中东·非洲的过敏疾病标靶药物的市场占有率:各用途(2019年～2030年)
  • 中东·非洲的过敏疾病标靶药物的市场规模:各国
    • 中东·非洲的过敏疾病标靶药物的市场规模:各国(2019年·2023年·2030年)
    • 中东·非洲的过敏疾病标靶药物的市场规模:各国(2019年～2024年)
    • 中东·非洲的过敏疾病标靶药物的市场规模:各国(2025年～2030年)
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 土耳其

第12章 主要企业的简介

  • Sanofi
  • AbbVie
  • Novartis
  • Incyte
  • Roche
  • AstraZeneca
  • GSK
  • Eli Lilly and Company
  • Amgen
  • Pfizer
  • Leo Pharma
  • TEVA
  • Otsuka Pharmaceutical
  • Mabpharm
  • Keymed Biosciences
  • Genrix Bio
  • Dragon Boat Pharmaceutical
  • Jiangsu Hengrui Pharmaceuticals
  • Sunshine Guojian
  • Qyuns Therapeutics
  • Biosion

第13章 分析师的观点/结论

第14章 附录

The global Targeted Drugs for Allergic Diseases market is projected to grow from US$ 37,149.12 million in 2024 to US$ 91,069.96 million by 2030, at a Compound Annual Growth Rate (CAGR) of 16.12% during the forecast period.

The US & Canada market for Targeted Drugs for Allergic Diseases is estimated to increase from $ 24,817.98 million in 2024 to reach $ 47,449.29 million by 2030, at a CAGR of 11.41% during the forecast period of 2025 through 2030.

The China market for Targeted Drugs for Allergic Diseases is estimated to increase from $ 2,303.36 million in 2024 to reach $ 16,524.16 million by 2030, at a CAGR of 38.88% during the forecast period of 2025 through 2030.

The Europe market for Targeted Drugs for Allergic Diseases is estimated to increase from $ 6,593.13 million in 2024 to reach $ 15,704.86 million by 2030, at a CAGR of 15.56% during the forecast period of 2025 through 2030.

The global key companies of Targeted Drugs for Allergic Diseases include Sanofi, AbbVie, Novartis, Incyte, Roche, AstraZeneca, GSK, Eli Lilly and Company, Amgen, Pfizer, Leo Pharma, Teva, Otsuka Pharmaceutical, Mabpharm etc. In 2023, the global top five players had a share approximately 75.25 % in terms of revenue.

Report Includes

This report presents an overview of global market for Targeted Drugs for Allergic Diseases market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Targeted Drugs for Allergic Diseases, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Targeted Drugs for Allergic Diseases, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Targeted Drugs for Allergic Diseases revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Targeted Drugs for Allergic Diseases market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Targeted Drugs for Allergic Diseases revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Sanofi, Novartis, GSK, Amgen, AstraZeneca, Pfizer, TEVA, Otsuka Pharmaceutical, and Roche, etc.

Market Segmentation

By Company

  • Sanofi
  • AbbVie
  • Novartis
  • Incyte
  • Roche
  • AstraZeneca
  • GSK
  • Eli Lilly and Company
  • Amgen
  • Pfizer
  • Leo Pharma
  • Teva
  • Otsuka Pharmaceutical
  • Mabpharm
  • Keymed Biosciences
  • Genrix Bio
  • Dragon Boat Pharmaceutical
  • Jiangsu Hengrui Pharmaceuticals
  • Sunshine Guojian
  • Qyuns Therapeutics
  • Biosion

Segment by Type

  • IL-4R
  • TSLP
  • IL-5
  • JAK
  • IgE
  • IL-13
  • Others

Segment by Application

  • Atopic Dermatitis
  • Asthma
  • Chronic Sinusitis with Nasal Polyps
  • Chronic Obstructive Pulmonary Disease
  • Others

By Region

  • North America
  • United States
  • Canada
  • China
  • Asia (excluding China)
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Europe
  • Germany
  • France
  • UK
  • Russia
  • Italy
  • Other
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Other
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Turkey
  • Other

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of Targeted Drugs for Allergic Diseases in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Targeted Drugs for Allergic Diseases companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.

Chapter 7: Europe by Type, by Application and by country, revenue for each segment.

Chapter 8: China by Type, and by Application, revenue for each segment.

Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Targeted Drugs for Allergic Diseases revenue, gross margin, and recent development, etc.

Chapter 12: Analyst's Viewpoints/Conclusions

Table of Contents

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Targeted Drugs for Allergic Diseases Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
    • 1.2.2 IL-4R
    • 1.2.3 TSLP
    • 1.2.4 IL-5
    • 1.2.5 JAK
    • 1.2.6 IgE
    • 1.2.7 IL-13
  • 1.3 Market by Application
    • 1.3.1 Global Targeted Drugs for Allergic Diseases Market Share by Application: 2019 VS 2023 VS 2030
    • 1.3.2 Atopic Dermatitis
    • 1.3.3 Asthma
    • 1.3.4 Chronic Sinusitis with Nasal Polyps
    • 1.3.5 Chronic Obstructive Pulmonary Disease
    • 1.3.6 Others
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Targeted Drugs for Allergic Diseases Market Perspective (2019-2030)
  • 2.2 Global Targeted Drugs for Allergic Diseases Growth Trends by Region
    • 2.2.1 Global Targeted Drugs for Allergic Diseases Market Size by Region: 2019 VS 2023 VS 2030
    • 2.2.2 Targeted Drugs for Allergic Diseases Historic Market Size by Region (2019-2024)
    • 2.2.3 Targeted Drugs for Allergic Diseases Forecasted Market Size by Region (2025-2030)
  • 2.3 Targeted Drugs for Allergic Diseases Market Dynamics
    • 2.3.1 Targeted Drugs for Allergic Diseases Industry Trends
    • 2.3.2 Targeted Drugs for Allergic Diseases Market Drivers
    • 2.3.3 Targeted Drugs for Allergic Diseases Market Challenges
    • 2.3.4 Targeted Drugs for Allergic Diseases Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Revenue Targeted Drugs for Allergic Diseases by Players
    • 3.1.1 Global Targeted Drugs for Allergic Diseases Revenue by Players (2019-2024)
    • 3.1.2 Global Targeted Drugs for Allergic Diseases Revenue Market Share by Players (2019-2024)
  • 3.2 Global Targeted Drugs for Allergic Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players of Targeted Drugs for Allergic Diseases, Ranking by Revenue, 2022 VS 2023 VS 2024
  • 3.4 Global Targeted Drugs for Allergic Diseases Market Concentration Ratio
    • 3.4.1 Global Targeted Drugs for Allergic Diseases Market Concentration Ratio (CR5)
    • 3.4.2 Global Top 5 Companies by Targeted Drugs for Allergic Diseases Revenue in 2023
  • 3.5 Global Key Players of Targeted Drugs for Allergic Diseases Head office and Area Served
  • 3.6 Global Key Players of Targeted Drugs for Allergic Diseases Product Type
  • 3.7 Global Key Players Established Date of Targeted Drugs for Allergic Diseases
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Targeted Drugs for Allergic Diseases Breakdown Data by Type

  • 4.1 Global Targeted Drugs for Allergic Diseases Historic Market Size by Type (2019-2024)
  • 4.2 Global Targeted Drugs for Allergic Diseases Forecasted Market Size by Type (2025-2030)

5 Targeted Drugs for Allergic Diseases Breakdown Data by Application

  • 5.1 Global Targeted Drugs for Allergic Diseases Historic Market Size by Application (2019-2024)
  • 5.2 Global Targeted Drugs for Allergic Diseases Forecasted Market Size by Application (2025-2030)

6 North America

  • 6.1 North America Targeted Drugs for Allergic Diseases Market Size (2019-2030)
  • 6.2 North America Targeted Drugs for Allergic Diseases Market Size by Type
    • 6.2.1 North America Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024)
    • 6.2.2 North America Targeted Drugs for Allergic Diseases Market Size by Type (2025-2030)
    • 6.2.3 North America Targeted Drugs for Allergic Diseases Market Share by Type (2019-2030)
  • 6.3 North America Targeted Drugs for Allergic Diseases Market Size by Application
    • 6.3.1 North America Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024)
    • 6.3.2 North America Targeted Drugs for Allergic Diseases Market Size by Application (2025-2030)
    • 6.3.3 North America Targeted Drugs for Allergic Diseases Market Share by Application (2019-2030)
  • 6.4 North America Targeted Drugs for Allergic Diseases Market Size by Country
    • 6.4.1 North America Targeted Drugs for Allergic Diseases Market Size by Country: 2019 VS 2023 VS 2030
    • 6.4.2 North America Targeted Drugs for Allergic Diseases Market Size by Country (2019-2024)
    • 6.4.3 North America Targeted Drugs for Allergic Diseases Market Share by Country (2025-2030)
    • 6.4.4 United States
    • 6.4.5 Canada

7 Europe

  • 7.1 Europe Targeted Drugs for Allergic Diseases Market Size (2019-2030)
  • 7.2 Europe Targeted Drugs for Allergic Diseases Market Size by Type
    • 7.2.1 Europe Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024)
    • 7.2.2 Europe Targeted Drugs for Allergic Diseases Market Size by Type (2025-2030)
    • 7.2.3 Europe Targeted Drugs for Allergic Diseases Market Share by Type (2019-2030)
  • 7.3 Europe Targeted Drugs for Allergic Diseases Market Size by Application
    • 7.3.1 Europe Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024)
    • 7.3.2 Europe Targeted Drugs for Allergic Diseases Market Size by Application (2025-2030)
    • 7.3.3 Europe Targeted Drugs for Allergic Diseases Market Share by Application (2019-2030)
  • 7.4 Europe Targeted Drugs for Allergic Diseases Market Size by Country
    • 7.4.1 Europe Targeted Drugs for Allergic Diseases Market Size by Country: 2019 VS 2023 VS 2030
    • 7.4.2 Europe Targeted Drugs for Allergic Diseases Market Size by Country (2019-2024)
    • 7.4.3 Europe Targeted Drugs for Allergic Diseases Market Size by Country (2025-2030)
    • 7.4.4 Germany
    • 7.4.5 France
    • 7.4.6 U.K.
    • 7.4.7 Italy
    • 7.4.8 Russia

8 China

  • 8.1 China Targeted Drugs for Allergic Diseases Market Size (2019-2030)
  • 8.2 China Targeted Drugs for Allergic Diseases Market Size by Type
    • 8.2.1 China Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024)
    • 8.2.2 China Targeted Drugs for Allergic Diseases Market Size by Type (2025-2030)
    • 8.2.3 China Targeted Drugs for Allergic Diseases Market Share by Type (2019-2030)
  • 8.3 China Targeted Drugs for Allergic Diseases Market Size by Application
    • 8.3.1 China Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024)
    • 8.3.2 China Targeted Drugs for Allergic Diseases Market Size by Application (2025-2030)
    • 8.3.3 China Targeted Drugs for Allergic Diseases Market Share by Application (2019-2030)

9 Asia (excluding China)

  • 9.1 Asia Targeted Drugs for Allergic Diseases Market Size (2019-2030)
  • 9.2 Asia Targeted Drugs for Allergic Diseases Market Size by Type
    • 9.2.1 Asia Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024)
    • 9.2.2 Asia Targeted Drugs for Allergic Diseases Market Size by Type (2025-2030)
    • 9.2.3 Asia Targeted Drugs for Allergic Diseases Market Share by Type (2019-2030)
  • 9.3 Asia Targeted Drugs for Allergic Diseases Market Size by Application
    • 9.3.1 Asia Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024)
    • 9.3.2 Asia Targeted Drugs for Allergic Diseases Market Size by Application (2025-2030)
    • 9.3.3 Asia Targeted Drugs for Allergic Diseases Market Share by Application (2019-2030)
  • 9.4 Asia Targeted Drugs for Allergic Diseases Market Size by Region
    • 9.4.1 Asia Targeted Drugs for Allergic Diseases Market Size by Region: 2019 VS 2023 VS 2030
    • 9.4.2 Asia Targeted Drugs for Allergic Diseases Market Size by Region (2019-2024)
    • 9.4.3 Asia Targeted Drugs for Allergic Diseases Market Size by Region (2025-2030)
    • 9.4.4 Japan
    • 9.4.5 South Korea
    • 9.4.6 Southeast Asia
    • 9.4.7 India
    • 9.4.8 Australia

10 Latin America

  • 10.1 Latin America Targeted Drugs for Allergic Diseases Market Size (2019-2030)
  • 10.2 Latin America Targeted Drugs for Allergic Diseases Market Size by Type
    • 10.2.1 Latin America Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024)
    • 10.2.2 Latin America Targeted Drugs for Allergic Diseases Market Size by Type (2025-2030)
    • 10.2.3 Latin America Targeted Drugs for Allergic Diseases Market Share by Type (2019-2030)
  • 10.3 Latin America Targeted Drugs for Allergic Diseases Market Size by Application
    • 10.3.1 Latin America Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024)
    • 10.3.2 Latin America Targeted Drugs for Allergic Diseases Market Size by Application (2025-2030)
    • 10.3.3 Latin America Targeted Drugs for Allergic Diseases Market Share by Application (2019-2030)
  • 10.4 Latin America Targeted Drugs for Allergic Diseases Market Size by Country
    • 10.4.1 Latin America Targeted Drugs for Allergic Diseases Market Size by Country: 2019 VS 2023 VS 2030
    • 10.4.2 Latin America Targeted Drugs for Allergic Diseases Market Size by Country (2019-2024)
    • 10.4.3 Latin America Targeted Drugs for Allergic Diseases Market Size by Country (2025-2030)
    • 10.4.4 Brazil
    • 10.4.5 Mexico
    • 10.4.6 Argentina
    • 10.4.7 Colombia

11 Middle East & Africa

  • 11.1 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size (2019-2030)
  • 11.2 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Type
    • 11.2.1 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024)
    • 11.2.2 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Type (2025-2030)
    • 11.2.3 Middle East & Africa Targeted Drugs for Allergic Diseases Market Share by Type (2019-2030)
  • 11.3 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Application
    • 11.3.1 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024)
    • 11.3.2 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Application (2025-2030)
    • 11.3.3 Middle East & Africa Targeted Drugs for Allergic Diseases Market Share by Application (2019-2030)
  • 11.4 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Country
    • 11.4.1 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Country: 2019 VS 2023 VS 2030
    • 11.4.2 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Country (2019-2024)
    • 11.4.3 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Country (2025-2030)
    • 11.4.4 Saudi Arabia
    • 11.4.5 UAE
    • 11.4.6 Turkey

12 Key Players Profiles

  • 12.1 Sanofi
    • 12.1.1 Sanofi Company Details
    • 12.1.2 Sanofi Business Overview
    • 12.1.3 Sanofi Targeted Drugs for Allergic Diseases Introduction
    • 12.1.4 Sanofi Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024)
    • 12.1.5 Sanofi Recent Development
  • 12.2 AbbVie
    • 12.2.1 AbbVie Company Details
    • 12.2.2 AbbVie Business Overview
    • 12.2.3 AbbVie Targeted Drugs for Allergic Diseases Introduction
    • 12.2.4 AbbVie Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024)
    • 12.2.5 AbbVie Recent Development
  • 12.3 Novartis
    • 12.3.1 Novartis Company Details
    • 12.3.2 Novartis Business Overview
    • 12.3.3 Novartis Targeted Drugs for Allergic Diseases Introduction
    • 12.3.4 Novartis Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024)
    • 12.3.5 Novartis Recent Development
  • 12.4 Incyte
    • 12.4.1 Incyte Company Details
    • 12.4.2 Incyte Business Overview
    • 12.4.3 Incyte Targeted Drugs for Allergic Diseases Introduction
    • 12.4.4 Incyte Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024)
    • 12.4.5 Incyte Recent Development
  • 12.5 Roche
    • 12.5.1 Roche Company Details
    • 12.5.2 Roche Business Overview
    • 12.5.3 Roche Targeted Drugs for Allergic Diseases Introduction
    • 12.5.4 Roche Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024)
    • 12.5.5 Roche Recent Development
  • 12.6 AstraZeneca
    • 12.6.1 AstraZeneca Company Details
    • 12.6.2 AstraZeneca Business Overview
    • 12.6.3 AstraZeneca Targeted Drugs for Allergic Diseases Introduction
    • 12.6.4 AstraZeneca Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024)
    • 12.6.5 AstraZeneca Recent Development
  • 12.7 GSK
    • 12.7.1 GSK Company Details
    • 12.7.2 GSK Business Overview
    • 12.7.3 GSK Targeted Drugs for Allergic Diseases Introduction
    • 12.7.4 GSK Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024)
    • 12.7.5 GSK Recent Development
  • 12.8 Eli Lilly and Company
    • 12.8.1 Eli Lilly and Company Company Details
    • 12.8.2 Eli Lilly and Company Business Overview
    • 12.8.3 Eli Lilly and Company Targeted Drugs for Allergic Diseases Introduction
    • 12.8.4 Eli Lilly and Company Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024)
    • 12.8.5 Eli Lilly and Company Recent Development
  • 12.9 Amgen
    • 12.9.1 Amgen Company Details
    • 12.9.2 Amgen Business Overview
    • 12.9.3 Amgen Targeted Drugs for Allergic Diseases Introduction
    • 12.9.4 Amgen Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024)
    • 12.9.5 Amgen Recent Development
  • 12.10 Pfizer
    • 12.10.1 Pfizer Company Details
    • 12.10.2 Pfizer Business Overview
    • 12.10.3 Pfizer Targeted Drugs for Allergic Diseases Introduction
    • 12.10.4 Pfizer Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024)
    • 12.10.5 Pfizer Recent Development
  • 12.11 Leo Pharma
    • 12.11.1 Leo Pharma Company Details
    • 12.11.2 Leo Pharma Business Overview
    • 12.11.3 Leo Pharma Targeted Drugs for Allergic Diseases Introduction
    • 12.11.4 Leo Pharma Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024)
    • 12.11.5 Leo Pharma Recent Development
  • 12.12 TEVA
    • 12.12.1 TEVA Company Details
    • 12.12.2 TEVA Business Overview
    • 12.12.3 TEVA Targeted Drugs for Allergic Diseases Introduction
    • 12.12.4 TEVA Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024)
    • 12.12.5 TEVA Recent Development
  • 12.13 Otsuka Pharmaceutical
    • 12.13.1 Otsuka Pharmaceutical Company Details
    • 12.13.2 Otsuka Pharmaceutical Business Overview
    • 12.13.3 Otsuka Pharmaceutical Targeted Drugs for Allergic Diseases Introduction
    • 12.13.4 Otsuka Pharmaceutical Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024)
    • 12.13.5 Otsuka Pharmaceutical Recent Development
  • 12.14 Mabpharm
    • 12.14.1 Mabpharm Company Details
    • 12.14.2 Mabpharm Business Overview
    • 12.14.3 Mabpharm Targeted Drugs for Allergic Diseases Introduction
    • 12.14.4 Mabpharm Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024)
    • 12.14.5 Mabpharm Recent Development
  • 12.15 Keymed Biosciences
    • 12.15.1 Keymed Biosciences Company Details
    • 12.15.2 Keymed Biosciences Business Overview
    • 12.15.3 Keymed Biosciences Targeted Drugs for Allergic Diseases Introduction
    • 12.15.4 Keymed Biosciences Recent Development
  • 12.16 Genrix Bio
    • 12.16.1 Genrix Bio Company Details
    • 12.16.2 Genrix Bio Business Overview
    • 12.16.3 Genrix Bio Targeted Drugs for Allergic Diseases Introduction
    • 12.16.4 Genrix Bio Recent Development
  • 12.17 Dragon Boat Pharmaceutical
    • 12.17.1 Dragon Boat Pharmaceutical Company Details
    • 12.17.2 Dragon Boat Pharmaceutical Business Overview
    • 12.17.3 Dragon Boat Pharmaceutical Targeted Drugs for Allergic Diseases Introduction
  • 12.18 Jiangsu Hengrui Pharmaceuticals
    • 12.18.1 Jiangsu Hengrui Pharmaceuticals Company Details
    • 12.18.2 Jiangsu Hengrui Pharmaceuticals Business Overview
    • 12.18.3 Jiangsu Hengrui Pharmaceuticals Targeted Drugs for Allergic Diseases Introduction
    • 12.18.4 Jiangsu Hengrui Pharmaceuticals Recent Development
  • 12.19 Sunshine Guojian
    • 12.19.1 Sunshine Guojian Company Details
    • 12.19.2 Sunshine Guojian Business Overview
    • 12.19.3 Sunshine Guojian Targeted Drugs for Allergic Diseases Introduction
    • 12.19.4 Sunshine Guojian Recent Development
  • 12.20 Qyuns Therapeutics
    • 12.20.1 Qyuns Therapeutics Company Details
    • 12.20.2 Qyuns Therapeutics Business Overview
    • 12.20.3 Qyuns Therapeutics Targeted Drugs for Allergic Diseases Introduction
    • 12.20.4 Qyuns Therapeutics Recent Development
  • 12.21 Biosion
    • 12.21.1 Biosion Company Details
    • 12.21.2 Biosion Business Overview
    • 12.21.3 Biosion Targeted Drugs for Allergic Diseases Introduction
    • 12.21.4 Biosion Recent Development

13 Analyst's Viewpoints/Conclusions

14 Appendix

  • 14.1 Research Methodology
    • 14.1.1 Methodology/Research Approach
    • 14.1.2 Data Source
  • 14.2 Author Details
  • 14.3 Disclaimer

List of Tables

  • Table 1. Global Targeted Drugs for Allergic Diseases Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
  • Table 2. Key Players of IL-4R
  • Table 3. Key Players of TSLP
  • Table 4. Key Players of IL-5
  • Table 5. Key Players of JAK
  • Table 6. Key Players of IgE
  • Table 7. Key Players of IL-13
  • Table 8. Global Targeted Drugs for Allergic Diseases Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
  • Table 9. Global Targeted Drugs for Allergic Diseases Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
  • Table 10. Global Targeted Drugs for Allergic Diseases Market Size by Region (2019-2024) & (US$ Million)
  • Table 11. Global Targeted Drugs for Allergic Diseases Market Share by Region (2019-2024)
  • Table 12. Global Targeted Drugs for Allergic Diseases Forecasted Market Size by Region (2025-2030) & (US$ Million)
  • Table 13. Global Targeted Drugs for Allergic Diseases Market Share by Region (2025-2030)
  • Table 14. Targeted Drugs for Allergic Diseases Market Trends
  • Table 15. Targeted Drugs for Allergic Diseases Market Drivers
  • Table 16. Targeted Drugs for Allergic Diseases Market Challenges
  • Table 17. Targeted Drugs for Allergic Diseases Market Restraints
  • Table 18. Global Targeted Drugs for Allergic Diseases Revenue by Players (2019-2024) & (US$ Million)
  • Table 19. Global Targeted Drugs for Allergic Diseases Market Share by Players (2019-2024)
  • Table 20. Global Top Targeted Drugs for Allergic Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Drugs for Allergic Diseases as of 2023)
  • Table 21. Global Targeted Drugs for Allergic Diseases Industry Ranking 2022 VS 2023
  • Table 22. Global 5 Largest Players Market Share by Targeted Drugs for Allergic Diseases Revenue (CR5) & (2019-2024)
  • Table 23. Global Key Players of Targeted Drugs for Allergic Diseases, Headquarters and Area Served
  • Table 24. Global Key Players of Targeted Drugs for Allergic Diseases Product Type
  • Table 25. Global Key Players Established Date of Targeted Drugs for Allergic Diseases
  • Table 26. Mergers & Acquisitions, Expansion Plans
  • Table 27. Global Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024) & (US$ Million)
  • Table 28. Global Targeted Drugs for Allergic Diseases Revenue Market Share by Type (2019-2024)
  • Table 29. Global Targeted Drugs for Allergic Diseases Forecasted Market Size by Type (2025-2030) & (US$ Million)
  • Table 30. Global Targeted Drugs for Allergic Diseases Revenue Market Share by Type (2025-2030)
  • Table 31. Global Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024) & (US$ Million)
  • Table 32. Global Targeted Drugs for Allergic Diseases Revenue Market Share by Application (2019-2024)
  • Table 33. Global Targeted Drugs for Allergic Diseases Forecasted Market Size by Application (2025-2030) & (US$ Million)
  • Table 34. Global Targeted Drugs for Allergic Diseases Revenue Market Share by Application (2025-2030)
  • Table 35. North America Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024) & (US$ Million)
  • Table 36. North America Targeted Drugs for Allergic Diseases Market Size by Type (2025-2030) & (US$ Million)
  • Table 37. North America Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024) & (US$ Million)
  • Table 38. North America Targeted Drugs for Allergic Diseases Market Size by Application (2025-2030) & (US$ Million)
  • Table 39. North America Targeted Drugs for Allergic Diseases Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
  • Table 40. North America Targeted Drugs for Allergic Diseases Market Size by Country (2019-2024) & (US$ Million)
  • Table 41. North America Targeted Drugs for Allergic Diseases Market Size by Country (2025-2030) & (US$ Million)
  • Table 42. Europe Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024) & (US$ Million)
  • Table 43. Europe Targeted Drugs for Allergic Diseases Market Size by Type (2025-2030) & (US$ Million)
  • Table 44. Europe Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024) & (US$ Million)
  • Table 45. Europe Targeted Drugs for Allergic Diseases Market Size by Application (2025-2030) & (US$ Million)
  • Table 46. Europe Targeted Drugs for Allergic Diseases Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
  • Table 47. Europe Targeted Drugs for Allergic Diseases Market Size by Country (2019-2024) & (US$ Million)
  • Table 48. Europe Targeted Drugs for Allergic Diseases Market Size by Country (2025-2030) & (US$ Million)
  • Table 49. China Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024) & (US$ Million)
  • Table 50. China Targeted Drugs for Allergic Diseases Market Size by Type (2025-2030) & (US$ Million)
  • Table 51. China Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024) & (US$ Million)
  • Table 52. China Targeted Drugs for Allergic Diseases Market Size by Application (2025-2030) & (US$ Million)
  • Table 53. Asia Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024) & (US$ Million)
  • Table 54. Asia Targeted Drugs for Allergic Diseases Market Size by Type (2025-2030) & (US$ Million)
  • Table 55. Asia Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024) & (US$ Million)
  • Table 56. Asia Targeted Drugs for Allergic Diseases Market Size by Application (2025-2030) & (US$ Million)
  • Table 57. Asia Targeted Drugs for Allergic Diseases Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
  • Table 58. Asia Targeted Drugs for Allergic Diseases Market Size by Region (2019-2024) & (US$ Million)
  • Table 59. Asia Targeted Drugs for Allergic Diseases Market Size by Region (2025-2030) & (US$ Million)
  • Table 60. Latin America Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024) & (US$ Million)
  • Table 61. Latin America Targeted Drugs for Allergic Diseases Market Size by Type (2025-2030) & (US$ Million)
  • Table 62. Latin America Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024) & (US$ Million)
  • Table 63. Latin America Targeted Drugs for Allergic Diseases Market Size by Application (2025-2030) & (US$ Million)
  • Table 64. Latin America Targeted Drugs for Allergic Diseases Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
  • Table 65. Latin America Targeted Drugs for Allergic Diseases Market Size by Country (2019-2024) & (US$ Million)
  • Table 66. Latin America Targeted Drugs for Allergic Diseases Market Size by Country (2025-2030) & (US$ Million)
  • Table 67. Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024) & (US$ Million)
  • Table 68. Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Type (2025-2030) & (US$ Million)
  • Table 69. Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024) & (US$ Million)
  • Table 70. Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Application (2025-2030) & (US$ Million)
  • Table 71. Middle East & Africa Targeted Drugs for Allergic Diseases Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
  • Table 72. Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Country (2019-2024) & (US$ Million)
  • Table 73. Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Country (2025-2030) & (US$ Million)
  • Table 74. Sanofi Company Details
  • Table 75. Sanofi Business Overview
  • Table 76. Sanofi Targeted Drugs for Allergic Diseases Product
  • Table 77. Sanofi Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) & (US$ Million)
  • Table 78. Sanofi Recent Development
  • Table 79. AbbVie Company Details
  • Table 80. AbbVie Business Overview
  • Table 81. AbbVie Targeted Drugs for Allergic Diseases Product
  • Table 82. AbbVie Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) & (US$ Million)
  • Table 83. AbbVie Recent Development
  • Table 84. Novartis Company Details
  • Table 85. Novartis Business Overview
  • Table 86. Novartis Targeted Drugs for Allergic Diseases Product
  • Table 87. Novartis Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) & (US$ Million)
  • Table 88. Novartis Recent Development
  • Table 89. Incyte Company Details
  • Table 90. Incyte Business Overview
  • Table 91. Incyte Targeted Drugs for Allergic Diseases Product
  • Table 92. Incyte Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) & (US$ Million)
  • Table 93. Incyte Recent Development
  • Table 94. Roche Company Details
  • Table 95. Roche Business Overview
  • Table 96. Roche Targeted Drugs for Allergic Diseases Product
  • Table 97. Roche Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) & (US$ Million)
  • Table 98. Roche Recent Development
  • Table 99. AstraZeneca Company Details
  • Table 100. AstraZeneca Business Overview
  • Table 101. AstraZeneca Targeted Drugs for Allergic Diseases Product
  • Table 102. AstraZeneca Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) & (US$ Million)
  • Table 103. AstraZeneca Recent Development
  • Table 104. GSK Company Details
  • Table 105. GSK Business Overview
  • Table 106. GSK Targeted Drugs for Allergic Diseases Product
  • Table 107. GSK Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) & (US$ Million)
  • Table 108. GSK Recent Development
  • Table 109. Eli Lilly and Company Company Details
  • Table 110. Eli Lilly and Company Business Overview
  • Table 111. Eli Lilly and Company Targeted Drugs for Allergic Diseases Product
  • Table 112. Eli Lilly and Company Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) & (US$ Million)
  • Table 113. Eli Lilly and Company Recent Development
  • Table 114. Amgen Company Details
  • Table 115. Amgen Business Overview
  • Table 116. Amgen Targeted Drugs for Allergic Diseases Product
  • Table 117. Amgen Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) & (US$ Million)
  • Table 118. Amgen Recent Development
  • Table 119. Pfizer Company Details
  • Table 120. Pfizer Business Overview
  • Table 121. Pfizer Targeted Drugs for Allergic Diseases Product
  • Table 122. Pfizer Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) & (US$ Million)
  • Table 123. Pfizer Recent Development
  • Table 124. Leo Pharma Company Details
  • Table 125. Leo Pharma Business Overview
  • Table 126. Leo Pharma Targeted Drugs for Allergic Diseases Product
  • Table 127. Leo Pharma Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) & (US$ Million)
  • Table 128. Leo Pharma Recent Development
  • Table 129. TEVA Company Details
  • Table 130. TEVA Business Overview
  • Table 131. TEVA Targeted Drugs for Allergic Diseases Product
  • Table 132. TEVA Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) & (US$ Million)
  • Table 133. TEVA Recent Development
  • Table 134. Otsuka Pharmaceutical Company Details
  • Table 135. Otsuka Pharmaceutical Business Overview
  • Table 136. Otsuka Pharmaceutical Targeted Drugs for Allergic Diseases Product
  • Table 137. Otsuka Pharmaceutical Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) & (US$ Million)
  • Table 138. Otsuka Pharmaceutical Recent Development
  • Table 139. Mabpharm Company Details
  • Table 140. Mabpharm Business Overview
  • Table 141. Mabpharm Targeted Drugs for Allergic Diseases Product
  • Table 142. Mabpharm Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) & (US$ Million)
  • Table 143. Mabpharm Recent Development
  • Table 144. Keymed Biosciences Company Details
  • Table 145. Keymed Biosciences Business Overview
  • Table 146. Keymed Biosciences Targeted Drugs for Allergic Diseases Product
  • Table 147. Keymed Biosciences Recent Development
  • Table 148. Genrix Bio Company Details
  • Table 149. Genrix Bio Business Overview
  • Table 150. Genrix Bio Targeted Drugs for Allergic Diseases Product
  • Table 151. Genrix Bio Recent Development
  • Table 152. Dragon Boat Pharmaceutical Company Details
  • Table 153. Dragon Boat Pharmaceutical Business Overview
  • Table 154. Dragon Boat Pharmaceutical Targeted Drugs for Allergic Diseases Product
  • Table 155. Jiangsu Hengrui Pharmaceuticals Company Details
  • Table 156. Jiangsu Hengrui Pharmaceuticals Business Overview
  • Table 157. Jiangsu Hengrui Pharmaceuticals Targeted Drugs for Allergic Diseases Product
  • Table 158. Jiangsu Hengrui Pharmaceuticals Recent Development
  • Table 159. Sunshine Guojian Company Details
  • Table 160. Sunshine Guojian Business Overview
  • Table 161. Sunshine Guojian Targeted Drugs for Allergic Diseases Product
  • Table 162. Sunshine Guojian Recent Development
  • Table 163. Qyuns Therapeutics Company Details
  • Table 164. Qyuns Therapeutics Business Overview
  • Table 165. Qyuns Therapeutics Targeted Drugs for Allergic Diseases Product
  • Table 166. Qyuns Therapeutics Recent Development
  • Table 167. Biosion Company Details
  • Table 168. Biosion Business Overview
  • Table 169. Biosion Targeted Drugs for Allergic Diseases Product
  • Table 170. Biosion Recent Development
  • Table 171. Research Programs/Design for This Report
  • Table 172. Key Data Information from Secondary Sources
  • Table 173. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Targeted Drugs for Allergic Diseases Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
  • Figure 2. Global Targeted Drugs for Allergic Diseases Market Share by Type: 2023 VS 2030
  • Figure 3. IL-4R Features
  • Figure 4. TSLP Features
  • Figure 5. IL-5 Features
  • Figure 6. JAK Features
  • Figure 7. IgE Features
  • Figure 8. IL-13 Features
  • Figure 9. Global Targeted Drugs for Allergic Diseases Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
  • Figure 10. Global Targeted Drugs for Allergic Diseases Market Share by Application: 2023 VS 2030
  • Figure 11. Atopic Dermatitis Case Studies
  • Figure 12. Asthma Case Studies
  • Figure 13. Chronic Sinusitis with Nasal Polyps Case Studies
  • Figure 14. Chronic Obstructive Pulmonary Disease Case Studies
  • Figure 15. Chronic spontaneous urticaria Case Studies
  • Figure 16. Eosinophilic asthma Case Studies
  • Figure 17. Allergic rhinitis Case Studies
  • Figure 18. Eosinophilic esophagitis Case Studies
  • Figure 19. Eosinophilic granulomatosis with polyangiitis Case Studies
  • Figure 20. Targeted Drugs for Allergic Diseases Report Years Considered
  • Figure 21. Global Targeted Drugs for Allergic Diseases Market Size (US$ Million), Year-over-Year: 2019-2030
  • Figure 22. Global Targeted Drugs for Allergic Diseases Market Size, (US$ Million), 2019 VS 2023 VS 2030
  • Figure 23. Global Targeted Drugs for Allergic Diseases Market Share by Region: 2023 VS 2030
  • Figure 24. Global Targeted Drugs for Allergic Diseases Market Share by Players in 2023
  • Figure 25. The Top 5 Players Market Share by Targeted Drugs for Allergic Diseases Revenue in 2023
  • Figure 26. North America Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 27. North America Targeted Drugs for Allergic Diseases Market Share by Type (2019-2030)
  • Figure 28. North America Targeted Drugs for Allergic Diseases Market Share by Application (2019-2030)
  • Figure 29. North America Targeted Drugs for Allergic Diseases Market Share by Country (2019-2030)
  • Figure 30. United States Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 31. Canada Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 32. Europe Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 33. Europe Targeted Drugs for Allergic Diseases Market Share by Type (2019-2030)
  • Figure 34. Europe Targeted Drugs for Allergic Diseases Market Share by Application (2019-2030)
  • Figure 35. Europe Targeted Drugs for Allergic Diseases Market Share by Country (2019-2030)
  • Figure 36. Germany Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 37. France Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 38. U.K. Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 39. Italy Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 40. Russia Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 41. China Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 42. China Targeted Drugs for Allergic Diseases Market Share by Type (2019-2030)
  • Figure 43. China Targeted Drugs for Allergic Diseases Market Share by Application (2019-2030)
  • Figure 44. Asia Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 45. Asia Targeted Drugs for Allergic Diseases Market Share by Type (2019-2030)
  • Figure 46. Asia Targeted Drugs for Allergic Diseases Market Share by Application (2019-2030)
  • Figure 47. Asia Targeted Drugs for Allergic Diseases Market Share by Region (2019-2030)
  • Figure 48. Japan Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 49. South Korea Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 50. Southeast Asia Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 51. India Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 52. Australia Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 53. Latin America Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 54. Latin America Targeted Drugs for Allergic Diseases Market Share by Type (2019-2030)
  • Figure 55. Latin America Targeted Drugs for Allergic Diseases Market Share by Application (2019-2030)
  • Figure 56. Latin America Targeted Drugs for Allergic Diseases Market Share by Country (2019-2030)
  • Figure 57. Brazil Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 58. Mexico Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 59. Argentina Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 60. Colombia Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 61. Middle East & Africa Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 62. Middle East & Africa Targeted Drugs for Allergic Diseases Market Share by Type (2019-2030)
  • Figure 63. Middle East & Africa Targeted Drugs for Allergic Diseases Market Share by Application (2019-2030)
  • Figure 64. Middle East & Africa Targeted Drugs for Allergic Diseases Market Share by Country (2019-2030)
  • Figure 65. Saudi Arabia Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 66. UAE Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 67. Turkey Targeted Drugs for Allergic Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 68. Sanofi Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2019-2024)
  • Figure 69. AbbVie Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2019-2024)
  • Figure 70. Novartis Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2019-2024)
  • Figure 71. Incyte Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2019-2024)
  • Figure 72. Roche Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2019-2024)
  • Figure 73. AstraZeneca Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2019-2024)
  • Figure 74. GSK Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2019-2024)
  • Figure 75. Eli Lilly and Company Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2019-2024)
  • Figure 76. Amgen Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2019-2024)
  • Figure 77. Pfizer Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2019-2024)
  • Figure 78. Leo Pharma Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2019-2024)
  • Figure 79. TEVA Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2019-2024)
  • Figure 80. Otsuka Pharmaceutical Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2019-2024)
  • Figure 81. Mabpharm Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2019-2024)
  • Figure 82. Bottom-up and Top-down Approaches for This Report
  • Figure 83. Data Triangulation
  • Figure 84. Key Executives Interviewed